# Sensitivity, movement and hormone papers

> Studies discussed at Specialized Telemed — The Specialized Telemed reading list brings together ipamorelin studies on sensitivity, bowel movement, weight, hormone release and a related safety signal.

**Reading list**

The papers gathered together, with their own titles intact.

## Sensitivity, surgery and emesis

For the site’s starting question, there is the [rat visceral-and-somatic sensitivity experiment](https://doi.org/10.2147/jep.s249747). The [adult bowel-resection trial](https://pubmed.ncbi.nlm.nih.gov/25331030/) supplies the clinical disappointment that matters to the movement story. The [ferret cisplatin study](https://pubmed.ncbi.nlm.nih.gov/39043357/) gives weight preservation and vomiting separate answers.

The endocrine papers explain why a compound introduced through growth-hormone release appears in this company. One item further below concerns [GSK894281, a different ghrelin-receptor agonist tested in rats](https://pubmed.ncbi.nlm.nih.gov/25722321/); that toxicology finding is discussed with its identity attached on [the hormone page](/selective-signal).

## References

[1] Attenuation of Visceral and Somatic Nociception by Ghrelin Mimetics https://doi.org/10.2147/jep.s249747
[2] Ipamorelin, the first selective growth hormone secretagogue https://pubmed.ncbi.nlm.nih.gov/9849822/
[3] Efficacy of ipamorelin, a novel ghrelin mimetic, in a rodent model of postoperative ileus https://pubmed.ncbi.nlm.nih.gov/19289567/
[4] Actions and therapeutic pathways of ghrelin for gastrointestinal disorders https://doi.org/10.1038/nrgastro.2009.72
[5] Prospective, randomized, controlled, proof-of-concept study of the ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients https://pubmed.ncbi.nlm.nih.gov/25331030/
[6] The growth hormone secretagogue receptor 1a agonists, anamorelin and ipamorelin, inhibit cisplatin-induced weight loss in ferrets: Anamorelin also exhibits anti-emetic effects via a central mechanism https://pubmed.ncbi.nlm.nih.gov/39043357/
[7] Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers https://pubmed.ncbi.nlm.nih.gov/10496658/
[8] Integrated approach to early detection of cardiovascular toxicity induced by a ghrelin receptor agonist https://pubmed.ncbi.nlm.nih.gov/25722321/

---

At Specialized Telemed I untangle published research about the gut and hormone signals; this is an editorial site, not a healthcare business, and none of it is medical advice.